University Of Southampton
Clinical trials sponsored by University Of Southampton, explained in plain language.
-
New drug targets genetic weakness in mesothelioma tumors
Disease control Not yet recruitingThis phase 2 trial tests a drug called BMS-986504 in 30 people with relapsed mesothelioma whose tumors have a specific genetic marker (MTAP deficiency). The drug aims to shrink tumors by blocking a protein cancer cells need to grow. Researchers will measure how many patients have…
Phase: PHASE2 • Sponsor: University of Southampton • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New supplement aims to ease menopause-related body changes in midlife women
Symptom relief Not yet recruitingThis study tests whether a 12-week nutritional supplement (containing myo-inositol, berberine, cinnamon, and chromium) can improve body composition and menopause symptoms in 80 women aged 38-55 who are experiencing irregular periods or related symptoms. Participants will take cap…
Phase: NA • Sponsor: University of Southampton • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New study seeks to help PCD patients navigate fertility and pregnancy
Knowledge-focused Not yet recruitingThis study works with patients and healthcare professionals to create educational resources about fertility and pregnancy for people with Primary Ciliary Dyskinesia (PCD). The goal is to develop a patient-friendly guide and a toolkit for doctors. The study will involve 30 partici…
Phase: NA • Sponsor: University of Southampton • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC